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Abstract 24 
The transmembrane glycoprotein E11/Podoplanin (Pdpn) has been implicated in the 25 
initial stages of osteocyte differentiation. However, its precise function and regulatory 26 
mechanisms are still unknown. Due to the known embryonic lethality induced by 27 
global Pdpn deletion, we have herein explored the effect of bone specific Pdpn 28 
knockdown on osteocyte form and function in the post-natal mouse. Extensive 29 
skeletal phenotyping of male and female 6-week-old Oc-cre;Pdpnflox/flox (cKO) mice 30 
and their Pdpnflox/flox controls (fl/fl) has revealed that Pdpn deletion significantly 31 
compromises tibial cortical bone microarchitecture in both sexes, albeit to different 32 
extents (P<0.05). Consistent with this, we observed an increase in stiffness in female 33 
cKO mice in comparison to fl/fl mice (P<0.01). Moreover, analysis of the osteocyte 34 
phenotype by phalloidin staining revealed a significant decrease in the dendrite 35 
volume (P<0.001) and length (P<0.001) in cKO mice in which deletion of Pdpn also 36 
modifies the bone anabolic loading response (P<0.05) in comparison to age-matched 37 
fl/fl mice. Together, these data confirm a regulatory role for Pdpn in osteocyte 38 
dendrite formation and as such, in the control of osteocyte function. As the osteocyte 39 
dendritic network is known to play vital roles in regulating bone 40 
modeling/remodelling, this highlights an essential role for Pdpn in bone homeostasis.  41 
 42 
 43 
 44 
 45 
 46 
 47 
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Introduction 48 
Osteocytes are the most numerous of all the cells within bone and are critical 49 
regulators of bone structure and function. Most original paradigms have proposed that 50 
osteocytes are passive in their formation (Skerry et al., 1989; Nefussi et al., 1991; 51 
Palumbo et al., 2004). Recent evidence, however, now indicates that initial 52 
‘embedding’ involves their active contribution with vital transcriptional and dramatic 53 
morphological transformations (Holmbeck et al., 2005). Osteocytes have a highly 54 
specialized morphology with numerous dendritic processes extending from their cell 55 
body, connecting them with other osteocytes and with cells lining the bone surfaces, 56 
creating a large syncytium to enable cell-cell communications. Osteocytes play an 57 
integral role in maintaining bone homeostasis by regulating bone modeling and 58 
remodeling through their production of the Wnt inhibitor sclerostin, and through 59 
communicating with bone-resorbing osteoclasts by RANKL production (Balemans et 60 
al., 2001; Xiong et al., 2011; Nakashima et al., 2011; Dallas et al., 2013).  61 
Although it is well recognized that osteocytes are derived from osteoblasts, the 62 
mechanisms which govern this transition (osteocytogenesis) are yet to be fully 63 
elucidated. Several different genes have been implicated in influencing 64 
osteocytogenesis, one of which encodes for E11/Podoplanin (Pdpn) (Zhang et al., 65 
2006). Pdpn is a mucin-like, transmembrane glycoprotein, which undergoes O-66 
glycosylation leading to the production of different glycoforms. Pdpn is up-regulated 67 
by hypoxia in the lung (Cao et al., 2003); IL-3 and PROX-1 in the lymphatic system 68 
(Hong et al., 2002; Groger et al., 2004) and by TGF-β in fibrosarcoma cells (Suzuki et 69 
al., 2005).  70 
Few studies have investigated the precise function of Pdpn in osteocytes. We have 71 
previously shown that Pdpn is expressed by early embedding osteocytes, thus 72 
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identifying it as a factor which likely contributes to the vital, early stages of osteocyte 73 
differentiation (Staines et al., 2016a). It is known that Pdpn expression in osteocytes 74 
is up-regulated in response to mechanical strain in vivo (Zhang et al., 2006) and that 75 
increased Pdpn expression, through overexpression in ROS 17/2.6 cells and through 76 
stabilization by proteasome inhibitors in MLO-A5 cells, leads to the formation of long 77 
dendritic processes (Sprague et al. 1996; Staines et al., 2016a). The formation of these 78 
cytoplasmic processes is abrogated in cells pre-treated with siRNA targeted against 79 
Pdpn (Zhang et al., 2006). Although these data support an important role for Pdpn in 80 
dendritic process formation, a key feature of the differentiating osteocyte, the 81 
underpinning mechanisms remain to be fully defined.  82 
Whilst in vitro studies are informative, to fully disclose the biological function of 83 
Pdpn during in vivo osteocytogenesis and bone modeling/remodeling, it is essential to 84 
study an in vivo model of Pdpn deletion to enable a thorough examination of its 85 
functional role. Global deletion of Pdpn is perinatal lethal due to the essential role of 86 
Pdpn in lung and epithelial cell function (Zhang et al., 2006). We have therefore 87 
generated a Pdpn conditional knockout mouse to examine how deletion of Pdpn 88 
influences osteocytogenesis and the skeletal phenotype of these mice. We have used 89 
the well-characterized osteocalcin (OC)-cre promotor mouse (Zhang et al., 2002) as 90 
the expression of osteocalcin by late osteoblasts ensures that we eliminate Pdpn 91 
expression from late osteoblasts as they transition to the osteocyte phenotype. Using 92 
an osteocyte-specific cre mouse would have invalidated our experimental approach as 93 
it would have precluded our ability to study the role of Pdpn in osteocyte formation; 94 
osteoblasts would already have undergone differentiation into osteocytes. It is also 95 
pertinent to add that an osteocyte specific cre-promotor mouse does not currently 96 
exist. Here we show that a significant reduction in the expression of Pdpn in mice 97 
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affects tibial microarchitecture, compromises osteocyte dendrite elongation and 98 
thereby implicating Pdpn as a regulator of both osteocyte form and function.  99 
Results 100 
Oc-cre mediated bone-specific deletion of Pdpn 101 
The genotypes from the breeding strategy were born at the expected Mendelian 102 
frequency, and all cKO mice exhibited survival indistinguishable from that of fl/fl 103 
control mice. To confirm that the Pdpn floxed allele was selectively deleted in bone in 104 
cKO mice, we performed PCR analysis using primers designed to specifically detect 105 
Pdpn alleles before (Tm1c) and after (Tm1d) cre-recombination. As expected, the 106 
Tm1d allele was only present in the cKO mice revealing selective deletion of Pdpn in 107 
bone (Fig. 1B). The presence of reduced levels of the retained Tm1c allele in the 108 
bones from cKO mice indicates that complete Pdpn deletion was, however, not 109 
achieved (Fig. 1B). This bone-selective hypomorphic expression of Pdpn in cKO mice 110 
was confirmed by immunohistochemical and immunoblotting data. In both genotypes, 111 
immunolabelling for Pdpn showed extensive expression throughout all soft tissues 112 
including the lung, kidney and liver (Fig. 1C). Pdpn immunolabelling was also 113 
observed in the growth plate chondrocytes of all mice (Fig. 1C). Osteoblasts in both 114 
the fl/fl and the cKO mice also stained positively for Pdpn. In the trabecular and 115 
cortical bone of the fl/fl mice, osteocytes and their dendritic processes exhibited 116 
positive immunolabelling for Pdpn (Fig. 1D). However, in the cKO mice, 117 
approximately 70% of osteocytes did not label positively for Pdpn, thereby indicating 118 
a significant reduction in bone Pdpn in these cKO mice (P<0.001; Fig. 1D & E). 119 
Similarly, western blotting revealed little Pdpn expression in the bones from cKO 120 
compared to fl/fl mice (Fig. 1F). Together these data confirm the hypomorphic loss of 121 
Pdpn expression selectively from bone in our cKO mice.  122 
6 
 
Bone-selective ablation of Pdpn has no effect on the gross skeletal phenotype 123 
Analysis of total body weight (g) of male or female 6-week old mice showed no 124 
significant differences between genotypes (male fl/fl – 20.4 ± 0.5; male cKO – 19.1 ± 125 
0.4; female fl/fl – 16.3 ± 0.6; female cKO – 16.2 ± 0.5; n>4/genotype/sex). Similarly, 126 
no differences were observed in the tibia lengths (mm) in cKO and fl/fl mice (male 127 
fl/fl – 16.2 ± 0.1; male cKO – 16.1 ± 0.2; female fl/fl – 15.6 ± 0.2; female cKO – 15.5 128 
± 0.1; n>4/genotype/sex). Whole mount skeletal staining of mice also revealed no 129 
obvious gross differences in Alcian blue or Alizarin Red staining between cKO and 130 
fl/fl mice (Fig. 1G & H). Gait parameters of freely moving mice using the CatWalk 131 
gait analysis system were also unchanged (Suppl. Fig 1). Together these data suggest 132 
that the bone-selective deletion of Pdpn has no effect on the gross skeletal phenotype 133 
of mice. 134 
Pdpn deletion significantly alters tibial cortical bone microarchitecture  135 
Assessment of cortical bone mass by µCT (CSA/mean cortical thickness) revealed 136 
that Pdpn deletion produces statistically significant alterations in tibial cortical mass 137 
and shape, to differing extents, in both male and female cKO compared to fl/fl control 138 
mice. Specifically, CSA is unaffected in female cKO mice but is significantly lower 139 
in male cKO compared with male fl/fl mice at ~40-65% of tibial length (P<0.05; Fig. 140 
2A). In addition, mean cross sectional thickness was significantly lower at several 141 
regions in male cKO compared to male fl/fl mice (P<0.05), however, Pdpn deletion 142 
resulted in an increase in mean cross sectional thickness at several regions along the 143 
tibial length in female cKO compared with fl/fl control mice (P<0.05; Fig. 2B). 144 
Together these data indicate that the conditional deletion of Pdpn produces a deficit in 145 
the cortical tibial microarchitecture in both male and female mice, with a greater 146 
effect observed in the male mice. Despite this, no significant differences were 147 
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observed in the trabecular bone volume/tissue volume (BV/TV), trabecular number 148 
(Tb.N), trabecular thickness (Tb.th), trabecular separation (Tb.Sp), or trabecular 149 
pattern factor (Tb.Pf) in male or female cKO mice in comparison to age-matched fl/fl 150 
control mice (Table 1). 151 
Hypomorphic deletion of Pdpn results in gender-dependent effects on tibial structural 152 
parameters 153 
To provide an estimate of tibial resistance to bending forces, we calculated second 154 
moment of area around minor (Imin) and major axes (Imax) (Fig. 3A & B).  This 155 
showed a reduction in Imin along the tibia length in female cKO compared to female 156 
fl/fl which was most pronounced in midshaft and distal tibia (P<0.05, Fig. 3A). 157 
Statically significant reduction in Imin was also apparent in the tibia of male cKO 158 
compared with their male fl/fl controls, less so at the midshaft but more proximally 159 
(P<0.05, Fig. 3A). Overall, the trend in cKO mice was for smooth lowering of Imin 160 
proximodistally, which contrasts markedly from fluctuations in Imin along the tibia 161 
length of age-matched fl/fl control mice. For Imax, the trend was similar for female 162 
cKO and their fl/fl controls (P<0.05, Fig. 3B), however, the effect in male cKO 163 
seemed to be more proximal and midshaft (P<0.05, Fig. 3B). Tibial ellipticity and 164 
resistance to torsion (J) was mostly affected in female cKO compared with female 165 
fl/fl (P<0.05, Fig. 3C & D) with only small regions affected in male cKO compared 166 
with their male controls (P<0.05, Fig. 3C & D). This suggests that tibiae in female 167 
cKO are weaker than in fl/fl control mice. Indeed our 3-point bending data shows a 168 
52% increase in stiffness in the female cKO in comparison to fl/fl mice (P<0.01; 169 
Table 2). No other significant differences were observed in bone strength, work to 170 
rupture or maximum load between genotypes in either gender (Table 2).  171 
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Bone selective Pdpn hypomorphism does not affect osteocyte differentiation but 172 
causes disruption of the osteocyte dendritic network 173 
To examine how Pdpn deletion affects osteocytogenesis, we examined the 174 
mineralization and differentiation potential of cultured primary calvaria osteoblasts 175 
from Pdpn cKO and fl/fl mice. Alizarin red staining (Fig. 4A) and subsequent 176 
quantification (Fig. 4B) revealed no significant differences in the mineralization 177 
capabaility of Pdpn cKO primary osteoblasts in comparison to fl/fl mice. Consistent 178 
with this, we observed no significant differences in the gene expression of the 179 
osteocyte markers Sost and Phex in our Pdpn cKO cells at days 0, 7, 14 and 21 of 180 
culture (Fig. 4C & D). Similarly, no significant differences in Dmp1 expression were 181 
observed at days 0, 7 and 14 although  at day 21 of culture, there was a small 182 
significant decrease in the expression of Dmp1 in our Pdpn cKO cultures (P<0.05; Fig. 183 
4E). Taken together, these data suggest that the bone selective hypomorphic deletion 184 
of Pdpn does not influence osteocyte differentiation. 185 
Due to the proposed role for Pdpn in osteocyte dendrite formation and elongation, we 186 
sought to determine whether Pdpn deletion modifies osteocyte organisation by 187 
measuring 3D morphometric parameters in high resolution images obtained from 188 
nano-CT at the tibia–fibula junction. Our morphometric evaluation of the cortical 189 
bone microarchitecture at the tibia–fibula junction shows that Pdpn deletion does not 190 
affect numbers of osteocyte lacunae (N.Lc/Ct.TV; Table 3) or lacunar volume 191 
(Lc.V/Ct.TV; Table 3). Interestingly, no significant effect on vascular porosity; canal 192 
number (N.Ca; Table 3), density (N.Ca/Ct.TV; Table 3) and volume (normalised by 193 
cortical tissue volume; Ca.V/Ct.TV; Table 3) was also evident in cKO bones.  194 
Due to the reported function of the osteocyte in regulating bone remodeling and 195 
phosphate homeostasis, we next sought to examine whether our cKO mice exhibit 196 
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differential expression of the osteocyte factor sclerostin, as well as serum phosphate. 197 
We observed no apparent differences in the expression of sclerostin in our cKO mice 198 
in comparison to fl/fl mice (Fig. 4F). Similarly, our assessment of osteoclast and 199 
osteoblast numbers by TRAP and H&E staining, respectively and found no significant 200 
differences in their number between cKO and fl/fl mice (Fig. 4G & H). Serum 201 
phosphate levels were also similar in cKO and fl/fl mice (Fig. 4I). The osteocyte and 202 
its canalicular-lacunar organisation also have another pivotal role in the bone’s 203 
adaptive response to mechanical stimuli. We therefore next sought to examine 204 
whether tibiae deficient in Pdpn exhibit a modified response to mechanical loading. 205 
As expected, and in line with previous data, fl/fl mice show a significant load-induced 206 
increase in cortical bone cross-sectional thickness at the proximal diaphysis region of 207 
the tibia (P<0.01, Fig. 5A - C). Although the scale of the load-induced increase was 208 
statistically smaller than in fl/fl mice (P<0.05), cKO mice also exhibited a significant 209 
increase in the tibial cross-sectional thickness in response to loading (P<0.05, Fig. 5A 210 
- C; compared to contralateral control). As expected, in both our fl/fl and cKO mice, a 211 
decrease in sclerostin immunolabelling was observed in cortical bone osteocytes of 212 
the loaded limb in comparison to osteocytes of the unloaded contralateral limb (Fig. 213 
5D). There were however no differences in osteocyte sclersotin expression between 214 
loaded bones from fl/fl and cKO mice (Fig. 5D). 215 
In the light of the relatively normal osteocyte organisation in cKO mice as disclosed 216 
by nano-CT (Table 3), the difference in response of cKO and fl/fl control mice to 217 
mechanical loading was somewhat surprising. Therefore, to determine whether this 218 
deficit in load-related bone adaptation was associated with any specific change in 219 
osteocyte morphology we next performed phalloidin staining of F-actin in fl/fl and 220 
cKO cortical bone. Subsequent 3D rendering (Fig. 5E) and quantitative analysis of 221 
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osteocytes in the diaphyseal cortical bone confirmed our nano-CT data and revealed 222 
no significant differences in the total number of osteocyte cell bodies (Fig. 5F), the 223 
osteocytes cell body volume (Fig. 5G) or the osteocyte cell body sphericity (Fig. 5H) 224 
in cKO bone in comparison to age-matched fl/fl bone. Similarly, no significant 225 
differences were observed in the number of dendrites formed (Fig. 5I). However, a 226 
significant decrease in the mean dendrite volume (Fig. 5J, P<0.001) and the dendrite 227 
lengths (Fig. 5K, P<0.001) was noted in cKO in comparison to fl/fl mice, suggestive 228 
of a role for Pdpn in attainment of fully developed dendrites. 229 
Discussion 230 
We, and others, have previously shown that Pdpn promotes osteocytogenesis and 231 
dendrite formation in vitro (Zhang et al., 2006; Staines et al., 2016a). Our studies, 232 
described herein, have for the first time successfully generated a bone-specific 233 
conditional Pdpn hypomorphic mouse and we have confirmed a role for Pdpn in the 234 
attainment of fully elongated osteocyte dendrites.  235 
Previous attempts to decipher the in vivo role of Pdpn in osteocytogenesis have 236 
involved global deletion of Pdpn in mice. In the lung, Pdpn is known as T1alpha or 237 
RT140 and it is expressed on the apical surface of the lung epithelial cells (Dobbs et 238 
al., 1988; Rishi et al., 1995). In mice, global deletion of this gene results in death at 239 
birth due to respiratory failure. This is associated with the failure of type II alveolar 240 
lung cells to differentiate into type I cells and as such, the lungs of these mice are 241 
unable to inflate as normal (Ramirez et al., 2003). T1alpha deletion in mice also 242 
produces lymphatic defects with pronounced lymphedema resulting in swelling of the 243 
limbs at birth (Schacht et al., 2003). A previous comprehensive study has attempted to 244 
analyze the effect of Pdpn deletion on the skeleton by generating a global Pdpn 245 
knock-out mouse by targeting exon 1 (Zhang et al., 2006). Whilst these mice did not 246 
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express Pdpn in bone, the animals died soon after birth from suspected lung defect. 247 
Although the authors were unable to study the effects of Pdpn deletion on the 248 
postnatal skeleton they were able to make some important observations. The general 249 
appearance of the embryonic Pdpn null and wild-type mice was similar. More 250 
specifically, they found no significant differences in the length or diameter of the 251 
femur, or in the femur cortical thickness. They did report an increase in the body 252 
weight of the Pdpn null mice, however this was attributed to lymphedema resulting 253 
from limb swelling (Zhang et al., 2006).  254 
By using the cre-LoxP system targeted to exon 3 of the Pdpn gene, we have generated 255 
bone specific conditional knockdown mice which exhibited survival indistinguishable 256 
from that of fl/fl control mice. This has for the first time allowed us to study the role 257 
of Pdpn in bone development in the post-natal mouse. The normal survival rates of 258 
cKO mice contrasts with perinatal lethality of global Pdpn-/- mice (Zhang et al., 2006). 259 
Here we used the well characterized osteocalcin-driven cre promotor to drive Pdpn 260 
deletion. Oc-cre expression has previously been reported to be exclusive to late 261 
osteoblasts, with onset of expression just before birth and continuing throughout the 262 
mature osteoblast lineage (Zhang et al., 2002). This has therefore allowed us to 263 
examine the structure and function of the postnatal skeleton in the presence of 264 
reduced Pdpn expression in bone, where we observed significant differences in tibial 265 
cortical bone microarchitecture and in the volume and length of osteocyte dendrites 266 
likely leading to downstream effects on the tibia’s anabolic response to loading.  267 
Osteocytes play a vital role in regulating bone remodeling and their vast dendritic 268 
network is critical to cell-cell communication, maintaining cell viability and allowing 269 
the transfer of nutrients and waste products (Dallas et al., 2013). Accumulating 270 
evidence has suggested that Pdpn may play a critical role in dendrite formation; in 271 
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MLO-Y4 cells, the deletion of Pdpn with siRNAs abrogated dendrite formation 272 
(Zhang et al., 2006). Conversely, the ectopic overexpression of Pdpn in keratinocytes 273 
induces plasma membrane extensions (Scholl et al., 1999), and in endothelial cells, 274 
the reorganisation of the actin cytoskeleton and the formation of long tube like 275 
structures (Schacht et al., 2003). Similarly, we have previously shown that 276 
stabilisation of Pdpn protein, through inhibition of endogenous proteasome activity, 277 
promotes dendrite formation through the RhoA/ROCK/ERM pathway (Staines et al., 278 
2016a). RhoA is a small GTPase and a master regulator of various cellular processes 279 
such as cytokinetics, cytoskeletal regulation, and cell migration (Takai et al., 2001). 280 
Pdpn is able to co-localise with the ezrin, radixin and moesin (ERM) family of 281 
proteins which are essential for the linkage of the actin cytoskeleton to the plasma 282 
membrane (Scholl et al., 1999; Martin-Villar et al., 2006; Martin-Villar et al., 2014). 283 
Our present data suggests that Pdpn deletion does not affect osteocyte differentiation 284 
and instead, strongly support a role for Pdpn in the formation of full length dendritic 285 
processes. Despite this, we did not observe any differences in the expression of 286 
factors involved in the osteocytic regulation of bone remodeling and phosphate 287 
homeostasis. Normal sclerostin expression in osteocytes within bone of Pdpn cKO 288 
mice is consistent with a lack of change in osteocyte number, shape and size in these 289 
mice. It is possible that the hypomorphic deletion of Pdpn expression in osteocytes 290 
does not affect the osteocyte’s ability to regulate bone remodeling. Rather, the 291 
decreased magnitude of bone accrual in response to mechanical loading is likely a 292 
consequence of inadequate dendrite formation and a lack of critical osteocyte 293 
mechanoregulatory function.  294 
Mechanosensation and mechanotransduction were the earliest functions ascribed to 295 
the osteocyte and since then, there has been a wealth of evidence defining their role 296 
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and in particular, the role of the dendritic network in sensing mechanical loads. In 297 
recent years, the complex biochemical pathways through which the osteocyte converts 298 
its mechanical strain signals into a biological output have been unravelled. These 299 
include intracellular calcium, nitric oxide, ATP and prostaglandins and these have 300 
direct effects on osteoblasts to alter the bone microarchitecture (Dallas et al., 2013). 301 
On this basis, we therefore speculate that the restricted osteocytic dendrite network 302 
observed in our hypomorphic Pdpn cKO mice would likely lead to altered bone 303 
geometry and microarchitecture; the reduced dendritic network impairs the ability of 304 
the osteocyte to sense load and convert this to a biological signal affecting osteoblast 305 
function. It would obviously therefore be of interest to examine the expression of the 306 
aforementioned biochemical pathways in our Pdpn cKO mice in response to loading. 307 
Moreover, as the bone mechanical properties, including stiffness, depend upon the 308 
geometry of the bone shaft, it is likely that the reduction of the osteocyte dendritic 309 
network affects the mechanical properties as a secondary effect through these changes 310 
in the microarchitecture (Saffar et al., 2009).  311 
Here we used whole bone µCT analysis to fully define these changes in 312 
microarchitecture and determine the estimated strength and rigidity of the bone 313 
through the study of the bone's cross sectional geometry. CSA is directly related to a 314 
bone's strength against compressive forces applied equally throughout the bone; 315 
factors such as bone shape and the effects of muscle contraction however result in 316 
long bones experiencing bending and torsional forces (Javaheri et al., 2015). We 317 
measured indices of rigidity, including maximum and minimum resistance against 318 
bending forces in the cross section, second moment of area around minor axis (Imin) 319 
and second moment of area around major axis (Imax) in male and female cKO tibia and 320 
their age-matched control mouse tibia. Our data, using this approach, revealed sex-321 
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dependent differences in cortical bone microarchitecture and in our estimation of 322 
tibial resistance to bending forces in cKO mice in comparison to control mice. These 323 
differences suggest that bone responses to dysfunctional osteocyte form and function 324 
may be sex-dependent. Similarly the differences in the regional responses in both 325 
male and female bones suggests that Pdpn may play differential roles in bone 326 
development and function. Interestingly, Bonewald and colleagues found osteocyte 327 
Pdpn expression was increased in an ulna loading model, but that this increase was 328 
not consistent along the length of the diaphysis (Zhang et al., 2006). This regional 329 
requirement for Pdpn function during physiological loading in the post-natal mouse 330 
may explain the differences noted in structural parameters of the Pdpn cKO mouse 331 
and in the relatively minor, albeit significant, reductions in load-related increases in 332 
cortical thickness in the bones of these mice.  333 
Despite these changes in bone microarchitecture and osteocyte form in our Pdpn cKO 334 
mice our data reveals no effect of Pdpn deletion on the gross phenotype. This 335 
suggests that whilst Pdpn plays a role in dendrite length and bone microarchitecture, 336 
there may be redundancy associated with the function of Pdpn. Possible candidates 337 
include Dentin matrix protein 1 (DMP1). DMP1 is an acidic phosphorylated 338 
extracellular matrix protein that is part of the Small; Integrin-Binding LIgand, N-339 
linked Glycoprotein (SIBLING) family along with bone sialoprotein (BSP), 340 
osteopontin (OPN), dentin sialophosphoprotein (DSPP) and matrix extracellular 341 
phosphoglycoprotein (MEPE). All of these family members contain an RGD 342 
sequence for integrin binding and can bind to hydroxyapatite (Staines et al., 2012). 343 
DMP1 is highly expressed by osteocytes and is restricted to the dendritic processes. 344 
Deletion of DMP1 in mice causes remarkable defects in both tooth and bone (Ye et 345 
al., 2004; Ye et al., 2005). DMP1 knockout mice also display an abnormal lacuna-346 
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canalicular system, with a reduction in the number of canaliculi and a 2-fold expanded 347 
osteocyte lacunae with rough, not smooth, lacunar walls (Lu et al., 2011). The authors 348 
of this elegant study also showed that this phenotype can be rescued by the re-349 
expression of the 57-kDa C-terminal fragment of DMP1 (Lu et al., 2011). DMP1 has 350 
been demonstrated to bind to the hyaluronan receptor CD44, a membrane bound 351 
protein thought to interact with the ERM family of proteins that are involved in actin 352 
cytoskeleton rearrangement and as such, the formation of the osteocyte dendritic 353 
processes (Jain et al., 2002).  354 
As we did not achieve complete cre-recombination and consequently not a complete 355 
knock-out of Pdpn expression (~70% reduction) it is also possible that a low level of 356 
Pdpn expression is sufficient to drive osteocytogenesis. A more complete knock-out 357 
of Pdpn expression may be required to reduce dendrite formation to a level where 358 
bone function is pathologically compromised. Our decision to use the osteocalcin-cre 359 
promotor mouse to drive deletion of Pdpn selectively in bone was based on the onset 360 
of OCN expression. Despite this, there have been previous reports of incomplete 361 
recombination when using these mice (Xiao et al., 2010). As such it might be prudent 362 
to attempt another cre driver mouse. Such examples would include the col 2.3 kb (Col 363 
2.3-Cre) and 3.6 kb (Col 3.6-Cre) fragments of the rat Col1a1 promoter or the osterix-364 
cre mouse (Liu et al., 2004; Rodda et al., 2006).  365 
In summary, our data confirm a role for Pdpn in the formation of full length dendritic 366 
processes during osteocytogenesis and suggest that dysfunctional osteocyte dendrite 367 
formation is sufficient to alter the bone microarchitecture. The generation of a viable 368 
post-natal bone specific Pdpn cKO will enable future research into understanding the 369 
importance of Pdpn in osteocyte function, and in particular to the in vivo effects of 370 
dysfunctional osteocyte formation on bone homeostasis. 371 
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Materials and methods 372 
Generation of a Pdpn conditional knockout mouse 373 
We obtained floxed Pdpn mice from the EUCOMM/KOMP, MRC Harwell, 374 
Oxfordshire UK and OC-cre mice as a kind gift from Thomas Clemens at John 375 
Hopkins Medicine, Baltimore, USA (Zhang et al., 2002). Pdpn floxed mice were 376 
designed with the loxP sites around exon 3 (Fig. 1A). Mice were crossed to generate 377 
Oc-Cre;Pdpnflox/flox conditional knockout mice (cKO) as well as appropriate 378 
Pdpnflox/flox control mice (fl/fl). PCR based genotyping was performed on mouse DNA 379 
using a duplex PCR reaction for Cre (F: GCA TTA CCG GTC GAT GCA ACG AGT 380 
GAT GAG; R: GAG TGA ACG AAC CTG GTC GAA ATC AGT GCG) and 381 
Fabpi200 (F: TGG ACA GGA CTG GAC CTC TGC TTT CCT AGA; R: TAG AGC 382 
TTT GCC ACA TCA CAG GTC ATT CAG) and for Pdpn (F: TCC CAC ACC AGG 383 
TTT TGT GT; R: CAG TGA GCC ATC TCT CCA GC). Mice were kept in 384 
polypropylene cages, with light/dark 12-h cycles, at 21 ± 2°C, and fed ad libitum with 385 
maintenance diet (Special Diet Services, Witham, UK). All experimental protocols 386 
were approved by Roslin Institute's Animal Users Committee and the animals were 387 
maintained in accordance with UK Home Office guidelines for the care and use of 388 
laboratory animals. All analysis and data acquisition were completed on 6-week-old 389 
mice and tissue obtained from them. 390 
Determination of Cre-mediated Recombination Efficiency 391 
To determine the specificity and efficiency of Cre-mediated recombination, PCR 392 
analysis was performed on genomic DNA extracted from bones using a Qiagen DNA 393 
extraction kit according to the manufacturer’s instructions. Primers were specific for 394 
alleles before recombination (Tm1c; F: TGG AAT GGC TGT GAG TTC TG; R: 395 
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CTA AAA TGG AGT TGG AGA TGG ATA C) and after recombination (Tm1d; F: 396 
TGA GCG AGC AGA GGT CCT AA; R: GCG TCT GGC ACT CTC AGA AG).  397 
Primary osteoblast isolation and culture 398 
Primary calvarial osteoblasts were obtained from 3-day-old Pdpn cKO and fl/fl mice 399 
by sequential enzyme digestion of excised calvarial bones using a four-step process as 400 
has previously been described (Staines et al., 2013) [1 mg/ml collagenase type II in 401 
Hanks' balanced salt solution (HBSS) for 10 min; 1 mg/ml collagenase type II in 402 
HBSS for 30 min; 4 mM EDTA for 10 min; 1 mg/ml collagenase type II in HBSS for 403 
30 min]. The first digest was discarded and the cells were re-suspended in growth 404 
medium consisting of a-MEM (Invitrogen, Paisley UK) supplemented with 10% (v/v) 405 
FCS (Invitrogen) and 1% gentamycin (Invitrogen). Osteoblasts were seeded at a 406 
density of 1 × 104 cells/cm2 and cultured for up to 21 days with the addition of 407 
2.5 mM β-glycerophosphate and 50 µg/ml ascorbic acid. At days 0, 7, 14 and 21, 408 
Cells were either processed for RNA extraction or fixed in 4% paraformaldehyde and 409 
stained with 2% alizarin red (pH 4.2) for 5 min at room temperature. Alizarin red-410 
stained cultures were extracted with 10% cetylpyridinium chloride for 10 min and 411 
optical density was measured at 570nm. 412 
Gait analysis 413 
Gait parameters of freely moving male mice were measured using the CatWalk gait 414 
analysis system (Noldus Information Technology, The Netherlands) as described 415 
previously (Masocha et al., 2009; Hammers et al., 2001). Each mouse was placed 416 
individually in the CatWalk walkway and allowed to walk freely and traverse from 417 
one side to the other of the walkway glass plate. Mice were habituated every day for 418 
two weeks prior to the test run, in which the gait of all mice was recorded three times 419 
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and analysed using the CatWalk system. Analysis of the recording generated a wide 420 
range of parameters; those analysed are detailed in Supplementary Table 1.  421 
In vivo loading 422 
12-week old male mice were isoflurane-anaesthetised and the right tibia loaded as 423 
described previously using a well-established model for comparing architectural load-424 
induced changes in tibiae in control and mutant mice in which the contralateral left 425 
tibia is used as control (De Souza et al., 2005). Briefly, axial compressive loads were 426 
applied by a servo-hydraulic materials testing machine (Bose, UK) via custom-made 427 
cups which hold knee and ankle joints flexed and the tibia vertically. The loading 428 
pattern consisted of a trapezoidal wave, with peak 11N loads for the cKO and 12N for 429 
the WT mice for 0.05 s, rise and fall times 0.025 s each and baseline hold time of 430 
9.9 s at 2 N (calibrated for peak strain level by finite element analysis) (Pereira et al., 431 
2015). Forty cycles were applied in each loading episode. 12-week old male cKO and 432 
WT mice (n>3/genotype) were loaded 3 times per week for 2 weeks and left and right 433 
tibia dissected 3 days after the final loading episode.  434 
Whole mount staining 435 
Male mice were euthanized by CO2 and incubated for 24 hours in tap water. Carcasses 436 
were then scalded in hot tap water to enable removal of the skin, skinned and 437 
eviscerated, and then fixed in 95% ethanol for 3-5 days. The preparations were then 438 
incubated in 0.015% Alcian blue (pH 0.75) for 24 hours to stain sulphated 439 
glycosaminoglycans in the cartilage, rinsed twice in 95% ethanol and fixed in 95% 440 
ethanol for another 2 days. Mice were then cleared of the remaining muscle by a 6 441 
hour incubation in 1% KOH (w/v) and the bone was stained with fresh 0.005% 442 
Alizarin Red for 3 hours. Mice were then further cleared in 2% KOH (w/v) for 48 443 
hours followed by decreasing concentrations of 2% KOH (w/v) in glycerol for 24 h 444 
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each (80:20, 60:40, 40:60 and 20:80, respectively). The skeletal preparations were 445 
stored in 20:80 2% KOH:glycerol at room temperature. 446 
Tissue processing for histological techniques 447 
Soft tissues (liver, spleen, lung, heart and kidney) and tibia/femurs were dissected 448 
from freshly killed male and female mice and fixed in 4% paraformaldehyde (PFA) 449 
for 24 hours at 4oC. Tibiae were subsequently decalcified in 10% 450 
ethylenediaminetetracetic acid (EDTA/PBS, pH 7.4 at 4oC; Sigma Aldrich, Dorset, 451 
UK) for 3-4 weeks with regular changes. Soft tissues and legs were dehydrated and 452 
processed to paraffin wax using standard procedures. Sections (5µm) were cut and 453 
used for histological and immunohistochemical analysis. To analyse osteoclast and 454 
osteoblast numbers, sections were reacted for tartrate-resistant acid phosphatase 455 
activity (TRAP) and stained by H&E respectively, as described previously 456 
(Erlebacher et al., 1996). Osteoclasts were quantified per mm2 of trabecular bone, and 457 
osteoblasts per mm of bone surface, in an identical region at an equivalent distance 458 
beneath the growth plate in all samples.  459 
Immunohistochemistry  460 
For immunohistochemical analysis, sections were dewaxed in xylene and rehydrated. 461 
Sections were incubated at 37 °C for 30 min in 1mg/ml trypsin for antigen demasking. 462 
Endogenous peroxidases were blocked by treatment with 3% H2O2 in methanol 463 
(Sigma). Ppdn antibodies (Polyclonal raised in Goat IgG; R&D systems) were used at 464 
a dilution of 1/100; and sclerostin antibodies (Polyclonal raised in Goat IgG; R&D 465 
systems) at a dilution of 1:200 with appropriate IgG controls. The Vectastain ABC 466 
universal kit (Vector Laboratories, Peterborough, UK) was used according to the 467 
manufacturer’s instructions. The sections were dehydrated, counterstained with 468 
haematoxylin and mounted in DePeX. 469 
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Phalloidin staining 470 
Femurs from male mice were decalcified as described above and then cryoprotected 471 
in 30% sucrose (w/v) at 4oC for 48 hours. The femora were cut in the mediolateral 472 
plane in serial longitudinal 20µm thick-sections using a cryostat and thaw-mounted on 473 
gelatin-coated slides for processing. Slides were dried at room temperature for 45 474 
minutes, washed in PBS twice for 5 min each, and incubated with 0.1% Triton-X 100 475 
(Sigma Aldrich) for 30 minutes and then rinsed with PBS. Slides were then incubated 476 
with Alexa Fluor 488-conjugated phalloidin (1:20; Life Technologies, Grand Island, 477 
NY) for 1 hour. Bone sections were washed in PBS and mounted in VectaShield 478 
(Vector Laboratories). Preparations were allowed to dry at room temperature for 12 479 
hours. 480 
Analysis of phalloidin staining 481 
Sections were imaged on a Zeiss LSM 710 Laser Scanning Confocal Microscope with 482 
488nm laser excitation and detection settings from 493 to 634nm. Z-stacks were 483 
produced with optimal Nyquist overlap settings using a 63x/1.4na oil immersion lens. 484 
Voxel sizes were 0.1x0.1x1.00µm in x,y,z planes respectively. A comparable region 485 
of interest was analysed for osteocyte parameters in all samples located in the 486 
diaphyseal cortical bone. Image stacks were imported into Bitplane Imaris 8.2.0 487 
software and algorithms were created with Imaris FilamentTracer to render and 488 
measure dendritic processes. Surface rendering was used for osteocyte cell body 489 
measurements.  490 
Micro-computed tomography (µCT) scanning 491 
Tibiae from male and female mice were dissected and frozen at -20oC until required. 492 
Scans were performed with an 1172 X-Ray Microtomograph (Skyscan, Belgium) to 493 
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evaluate bone geometry. High-resolution scans with an isotropic voxel size of 5 µm 494 
were acquired (50 kV, 200µA, 0.5 mm aluminium filter, 0.6° rotation angle, 2 frame 495 
averaging, exposure time 1650). The projection images were reconstructed using 496 
NRecon software version 1.6.9.4 (Skyscan, Belgium) to produce tomograms that 497 
underwent processing during reconstruction to correct for beam-hardening and ring 498 
artefacts. 499 
Morphometrical analysis 500 
a. Trabecular bone 501 
For the trabecular analysis, the base of the growth plate was used as a standard 502 
reference point. Trabecular bone was analysed in a 1mm region of the proximal tibia 503 
250 µm from this reference point (towards the diaphysis). Data were analysed with 504 
CtAn software (Skyscan) as previously described (Staines et al., 2016b).   505 
b.  Whole bone cortical µCT analysis  506 
Whole bone analysis was performed on datasets derived from whole CT scans using 507 
BoneJ (version 1.13.14) a plugin for ImageJ, as previously described (Javaheri et al., 508 
2015). Following segmentation, alignment and removal of fibula from the dataset, a 509 
minimum bone threshold was selected using a histogram based method in ImageJ 510 
which utilises all pixels in a stack to construct a histogram and was further confirmed 511 
using ImageJ “threshold function”. The grey level threshold ranged between 22000-512 
22100 and was applied to all datasets to separate higher density bone from soft tissues 513 
and air. This threshold was used in “Slice Geometry” function within BoneJ to 514 
calculate bone cross sectional area (CSA), second moment of area around the minor 515 
axis (Imin), second moment of area around the major axis (Imax), mean cortical 516 
thickness determined by local thickness in two dimensions (Ct.Th), ellipticity and 517 
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resistance to torsion (J). The most proximal and distal (10%) portions of the tibial 518 
length were excluded from analysis, as these regions include trabecular bone 519 
Nano-computed tomography analysis 520 
The samples were placed in Orthodontic Wax (Kerr, CA, USA) at 50 kV and 200 µA, 521 
9800 ms exposure time with a 0.25 mm aluminium filter (99.999% purity, 522 
Goodfellow, Huntington, UK), voxel size of 0.6 µm, 360° at a rotation step of 0.25°. 523 
Two-frame averaging was used to improve the signal-to-noise ratio. We analysed 300 524 
consecutive images from the tibia–fibula junction from each sample. Using the CtAn 525 
software, osteocyte lacunar indices were calculated by measuring the 3D parameters 526 
of each discreet object within the volume of interest after segmentation as described 527 
previously (Javaheri et al., 2015). Shape analysis of the lacunae was conducted 528 
utilizing ‘Analyze Particles’ function in BoneJ.  529 
Mechanical testing 530 
A Lloyd LRX5 materials testing machine (Lloyd Instruments, West Sussex, UK) 531 
fitted with a 100N load cell was used to determine bone stiffness and point of failure 532 
of tibiae. The span was fixed at 10 mm, and the cross-head was lowered at 1 mm/min. 533 
Data were recorded after every 0.2 mm change in deflection. Each bone was tested to 534 
failure, with failure points being identified as the point of maximum load from the 535 
load–extension curve. The maximum stiffness was defined as the maximum gradient 536 
of the rising portion of this curve (Huesa et al., 2011).  537 
RNA extraction and quantitative real-time PCR (RT-qPCR) 538 
Total RNA was extracted using the RNEasy mini kit (Qiagen) according to the 539 
manufacturer's instructions. RNA samples were reverse-transcribed into cDNA using 540 
Superscipt II reverse transcriptase (Invitrogen). RT-qPCR was carried out in a 541 
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Stratagene Mx3000P cycler with each reaction containing 50ng template DNA, 542 
250nM forward and reverse primers (Primer Design, Southampton UK) (Sost: F – 543 
TGAGAACAACCAGACCATGAAC, R – TCAGGAAGCGGGTGTAGTG; Dmp1: 544 
F – ATACCACAATACTGAATCTGAAAGC, R – 545 
CACTATTTGCCTGTCCCTCTG; Phex: F – CTAACCACCCACTCCCACTT, R – 546 
CCAATAGACTCCAAACCTGAAGA; Atp5b: sequences not available) and 547 
PrecisionPlus Mastermix (Primer Design). The Ct values for the samples were 548 
normalised to that of Gapdh and the relative expression was calculated using the 549 
ΔΔCt method (Livak and Schmittgen, 2001). The amplification efficiencies of all the 550 
primers were between 90–100%. 551 
Western blotting 552 
Femurs from male mice had their epiphyses removed and were flushed to remove 553 
bone marrow, snap frozen and lysed in RIPA buffer (Sigma), containing protease 554 
inhibitors (Roche). Protein content was determined using the DC protein assay (Bio-555 
Rad Laboratories). The lysates were run on 10% Bis–Tris gels. Following transfer, 556 
nitrocellulose films were blocked in 5% milk, and probed overnight at 4oC with Pdpn 557 
primary antibody (R&D systems; 1:1000). The nitrocellulose was subsequently 558 
incubated with peroxidase labelled rabbit anti-goat antibodies (Dako) for a further 559 
90 min. ECL detection reagents were used to visualise bands on hyperfilm (GE 560 
Healthcare, Bucks, UK). Where necessary, the nitrocellulose was stripped using 561 
Restore Plus Stripping Buffer (GE Healthcare). Densitometry of western blotting was 562 
measured on three independent samples using Image J.  563 
Serum phosphate analysis 564 
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Immediately before termination, blood was collected and incubated on ice for 30 565 
minutes, before centrifugation at 15,000g for 10 minutes. The serum supernatant was 566 
stored at -80°C until analysed for phosphate levels using a colorimetric Phosphate 567 
Assay Kit (Abcam; 1:100) according to the manufacturer’s instructions.  568 
Statistical analysis 569 
Data are expressed as the mean ± S.E.M of at least 3 replicates per experiment. 570 
Results were analysed blinded. For cortical bone, graphs were developed using the R 571 
programming language “R”, version 3.1.3 (R Foundation for Statistical Computing, 572 
Vienna, Austria; http://www.r-project.org).  Normality and homogeneity of variance 573 
of all the data were checked using the Shapiro-Wilk and the Bartlett’s test in R 3.1.3 574 
respectively. Two-sample Student’s-test was used to compare means between female 575 
cKO and fl/fl, and between male cKO and fl/fl.  Kruskal-Wallis test was employed if 576 
either the normality or the homogeneity of variance assumptions were violated (p ≥ 577 
0.05). P<0.05 was considered to be significant and noted as *; P values of <0.01 and 578 
<0.001 were noted as ‘**’ and ‘***’ respectively.  579 
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Figure Legends 737 
Figure 1. (A) Schematic of the Pdpn floxed allele before and after deletion of the 738 
loxP cassette containing exon 3 via osteocalcin cre (Oc-cre) mediated recombination. 739 
(B) PCR analysis of genomic DNA from the long bones of fl/fl, and cKO mice with 740 
primers for the Tm1c allele (before cre recombination), and the Tm1d allele (~440bp, 741 
after cre recombination). (C) Immunohistochemical labelling of Pdpn in the lung, 742 
kidney, spleen, heart, liver, muscle, and growth plate, of 6-week old mice. Images are 743 
representative of n=4/sex/genotype. Scale bar = 20µm. (D) Immunohistochemical 744 
labelling of Pdpn in the trabecular bone and cortical bone of 6-week old mice. Arrows 745 
are pointing at embedded osteocytes within the trabecular and cortical bone and their 746 
dendritic processes projecting from the cell bodies. Images are representative of 747 
n=4/sex/genotype. Scale bar = 20µm. (E) Quantification of osteocytes positive for 748 
Pdpn immunolabelling relative to negatively labelled osteocytes (n=3/genotype) 749 
P<0.001*** (F) Western blotting for Pdpn (~37kDa) in cortical bone protein lysates 750 
from 6-week old mice. β-actin was used as a loading control. Whole mount Alcian 751 
Blue and Alizarin Red stained skeletal preparations of 6- week old male (G) fl/fl, and 752 
(H) cKO mice (scale bar = 10mm) including hindlimb and calvaria preparations (scale 753 
bar = 5mm).  754 
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Figure 2. Whole bone analyses of cortical bone between 10–90% of total tibial length, 755 
excluding proximal and distal metaphyseal bone, of female fl/fl (brown), female cKO 756 
(orange), male fl/fl (black) and male cKO (grey) tibia at 6 weeks of age showing (A) 757 
cross sectional area (CSA; mm2) (B) mean cross sectional thickness (mm). Graphs 758 
represent mean ± S.E.M, n=4/group. P<0.05 was considered to be significant and P 759 
values of p≤0.01-0.05 were noted as green, p≤0.001-0.01 as yellow, and p≤0.000-760 
0.001 as red. Not significant is noted as blue.  761 
Figure 3. Whole bone analyses of cortical bone between 10–90% of total tibial length, 762 
excluding proximal and distal metaphyseal bone, of female fl/fl (brown), female cKO 763 
(orange), male fl/fl (black) and male cKO (grey) tibia at 6 weeks of age showing (A) 764 
Imin (mm4) (B) Imax (mm4) (C) ellipticity (D) resistance to torsion (J; mm4) Graphs 765 
represent mean ± S.E.M, n=4/group. P<0.05 was considered to be significant and P 766 
values of p≤0.01-0.05 were noted as green, p≤0.001-0.01 as yellow, and p≤0.000-767 
0.001 as red. Not significant is noted as blue. 768 
Figure 4. (A) Alizarin red staining of primary osteoblast cultures from Pdpn cKO and 769 
fl/fl mice over a 21 day culture period. (B) Quantification of Alizarin red staining. 770 
RT-qPCR analysis of osteocyte marker genes (C) Sost (D) Phex (E) Dmp1 in 771 
mineralizing primary osteoblast cultures from Pdpn cKO and fl/fl mice over a 21 day 772 
culture period. (F) Immunohistochemical labeling of sclerostin in the cortical bone of 773 
6-week old mice. Arrows are pointing at embedded osteocytes within the cortical 774 
bone and their dendritic processes projecting from the cell bodies. Images are 775 
representative of n=4/sex/genotype. Scale bar = 20µm. (G) Osteoclast cell numbers 776 
(OC.N/mm2) in the trabecular bone of 6-week old cKO and fl/fl mice (n=4/genotype) 777 
(H) Osteoblast cell numbers (OB.N/mm bone surface (BS)) in the trabecular bone of 778 
6-week old cKO and fl/fl mice (n=4/genotype) (I) Serum phosphate levels in cKO and 779 
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fl/fl mice (n=6/genotype). Data are represented as mean ± S.E.M. P<0.05*, P<0.01**, 780 
P<0.001***. 781 
Figure 5. Representative images of fl/fl and cKO mice in (A) control (B) loaded 782 
limbs. (C) Cortical cross-sectional thickness at 37% of the tibia length as assessed by 783 
microCT analysis. (D) Immunohistochemical labeling of sclerostin in osteocytes of 784 
cortical bone of loaded and control 6-week old Pdpn cKO and fl/fl mice. . Arrows are 785 
pointing at embedded osteocytes within the cortical bone and their dendritic processes 786 
projecting from the cell bodies. Images are representative of n=4/sex/genotype. Scale 787 
bar = 20µm. (E) Laser confocal z-stack, single channel outlining phalloidin-Factin 788 
staining was imaged in the cortical bone. Imaris cell surface rendering was applied to 789 
cell bodies and Imaris FilamentTracer applied to dendritic processes and these were 790 
coloured according to length. Quantification of osteocyte parameters in 6-week old 791 
male fl/fl, and cKO (F) Total number of complete cell bodies in 3 volume fields. (G) 792 
Cell body volume (µm3) (H) Cell body sphericity (I) Total number of dendrites in 3 793 
volume fields (J) Dendrite volume (µm3) (K) Dendrite length (µm). Data are 794 
represented as mean ± S.E.M. P<0.05*, P<0.01**, P<0.001***. 795 
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Suppl Fig 1 
Table 1: Trabecular parameters from microCT analysis of 6-week old male and female fl/fl, 
and cKO mice (n=4/genotype/sex). a P<0.05* in comparison to male equivalent genotype. Data 
are represented as mean ± S.E.M. 
 
Sex  BV/TV (%) Tb.N (µm
-
1) Tb.Th (µm) 
Tb.Sp 
(µm) 
Tb.Pf (µm-
1) 
M 
fl/fl 0.40 ± 0.05 1.14 ± 0.06 28.1 ± 3.53 1.19 ± 0.06 9.84 ± 3.71 
cKO 0.38 ± 0.03 1.12 ± 0.07 30.3 ± 1.57 1.11 ± 0.09 10.6 ± 3.12 
F 
fl/fl 0.23 ± 0.03a 1.19 ± 0.02 32.7 ± 1.65 0.96 ± 0.08 5.96 ± 3.05 
cKO 0.23 ± 0.03 1.07 ± 0.03 33.2 ± 3.36 1.12 ± 0.08 9.54 ± 2.68 
 
Table 2: 3 point bending analysis of 6-week old male and female fl/fl, and cKO mice 
(n=4/genotype/sex). Data are represented as mean ± S.E.M. a P<0.05* in comparison to male 
equivalent genotype. b P<0.01** in comparison to female fl/fl. Data are represented as mean ± 
S.E.M. 
 
 
Sex  Maximum load (N) 
Deflectio
n at 
Maximum 
Load 
(mm) 
Work to 
Maximum 
Load (J) 
Stiffness 
(N/m) 
Load at 
Rupture (N) 
Deflectio
n at 
Rupture 
(mm) 
Work to 
Rupture (J) 
M 
fl/fl 5.81 ± 0.65 
0.60 ± 
0.09 
0.002 ± 
0.00 
17.7 ± 
0.66 4.06 ± 0.45 
0.80 ± 
0.14 
0.003 ± 
0.00 
cKO 5.95 ± 0.26 
0.78 ± 
0.14 
0.002 ± 
0.00 
16.4 ± 
0.97 4.22 ± 0.19 
1.08 ± 
0.16 
0.004 ± 
0.00 
F 
fl/fl 4.58 ± 0.34 
0.66 ± 
0.04 
0.002 ± 
0.00 
12.6 ± 
1.42 3.21 ± 0.24
a 0.90 ± 0.02 
0.002 ± 
0.00 
cKO 5.30 ± 0.51 
0.68 ± 
0.06 
0.002 ± 
0.00 
19.1 ± 
1.44b 3.88 ± 0.36 
0.96 ± 
0.11 
0.003 ± 
0.00 
 
 
 
 
 
 
 
 
 
Table 3: Porosity parameters representing lacuna and vascular porosity of fl/fl and cKO mice 
detailing the effect of genotype. Data represent means ± SEM with group sizes of n = 4 for fl/fl 
and cKO mice. 
 
 
Morphometric 
index 
fl/fl cKO Effect of 
 n=4 n=4 Genotype 
Bone parameter    
Ct.TV (mm–3) 
 
Canal parameters 
0.101 ± 0.017 0.078 ± 0.003 NS 
N.Ca 52 ± 14.634 34 ± 12.124 NS 
N.Ca/Ct.TV (mm–3) 530 ± 169.45 419 ± 134.24 NS 
Ca.V/Ct.TV (%) 
 
0.005 ± 0.001 0.003 ± 0.001 NS 
Lacunae parameters    
N.Lc 1792 ± 353 1037 ± 383 NS 
N.Lc/Ct.TV (mm–3) 18611 ± 4505 13083 ± 4497 NS 
Lc.V/Ct.TV (%) 0.004 ± 0.000 0.003 ± 0.000 NS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
